¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2021 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãß°èÇмú´ëȸ-2ÀÏÂ÷ : 2021-11-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2021 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãß°èÇмú´ëȸ-2ÀÏÂ÷ : 2021-11-12
±³À°ÀÏÀÚ : 2021-11-12
±³À°Àå¼Ò : ¿Â¿ÀÇÁ¶óÀÎ(¿ÀÇÁ¶óÀÎ : ¼Ò³ëº§Á¦ÁÖ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) 2021 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãß°èÇмú´ëȸ-2ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ
´ã´çÀÚ : ¹Ú¼Ò¹Î
¿¬¶ôó : 02-398-5055  
À̸ÞÀÏ : office@kscpt.org      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ¸¶ÃëÅëÁõÀÇÇаú, º´¸®°ú, ÀÀ±ÞÀÇÇаú¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : Á¦ÁÖƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 6 ½Ã°£ 45ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í ÇöÀåÂü¼® - Á¤È¸¿ø 15¸¸¿ø, ÁØȸ¿ø 7¸¸¿ø, ºñȸ¿ø ÀÏ¹Ý 20¸¸¿ø, ºñȸ¿ø Çлý 10¸¸¿ø¿Â¶óÀÎ Âü¼® - Á¤È¸¿ø 12¸¸¿ø, ÁØȸ¿ø 5¸¸¿ø, ºñȸ¿ø ÀÏ¹Ý 17¸¸¿ø, ºñȸ¿ø Çлý 8¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-12 ¿Â¶óÀΠ09:00~11:30 Young scientist (Æ÷½ºÅÍ ¹ßÇ¥) + 1¸í( IUPHARÆ÷½ºÅÍ °æÁø´ëȸ ¼ö»óÀÚ¹ßÇ¥)  ¹ÌÁ¤(¹ÌÁ¤) 
±³À°½Ã°£ 11-12 ¿Â¶óÀΠ11:30~12:30 Back to BASIC: »ç¶÷À» »ì¸®´Â ½Å¾à°³¹ß  ¹èÁø°Ç ¹Ú»ç´Ô(À̳ëÅ¥¾î) 
±³À°½Ã°£ 11-12 ¿Â¶óÀΠ14:15~14:35 Model-informed drug development: an example of esaxerenone, a novel mineralocorticoid receptor blocker for hypertension  Dr. Masato Fukae((Daiichi Sankyo)) 
±³À°½Ã°£ 11-12 ¿Â¶óÀΠ14:35~15:00 Quantitative Predictive Models for the Degree of Disability over Time in Acute Ischemic Stroke Patients  Prof. Hyeong-Seok Lim((University of Ulsan)) 
±³À°½Ã°£ 11-12 ¿Â¶óÀΠ15:00~15:20 Current Status and Challenges of Model-Informed Drug Development and Model-Informed Precision Dosing in Japan  Dr. Sou Miyoshi((Pfizer R&D)) 
±³À°½Ã°£ 11-12 ¿Â¶óÀΠ15:20~15:40 Model Informed Precision Dosing Approach in cPMTb (Center for Personalized Precision Medicine of Tuberculosis)  Prof. Yong-Soon Cho((Inje University)) 
Åä·Ð 11-12 ¿Â¶óÀΠ15:40~15:55 Q&A  () 
±³À°½Ã°£ 11-12 ¿Â¶óÀΠ16:10~16:30 Prediction of transporter-mediated drug-drug interactions using the endogenous biomarkers  Dr. Hiroyuki Kusuhara((Graduate School of Pharmaceutical Sciences University of Tokyo)) 
±³À°½Ã°£ 11-12 ¿Â¶óÀΠ16:30~16:50 Development of metabolic biomarkers to control transplant rejection and long-term survival after kidney transplantation  Dr. Mi-Ri Gwon((Kyungpook National University)) 
±³À°½Ã°£ 11-12 ¿Â¶óÀΠ16:50~17:10 Screening of predictive biomarkers for drug efficacy and safety using lipidomics  Dr. Kosuke Saito((National Institute of Health Sciences)) 
±³À°½Ã°£ 11-12 ¿Â¶óÀΠ17:10~17:30 Prediction of CYP3A mediated drug-drug interaction using endogenous metabolic markers  Dr. Soyoung Lee((Seoul National University) 
Åä·Ð 11-12 ¿Â¶óÀΠ17:30~17:45 Q&A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2021 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãß°èÇмú´ëȸ-2ÀÏÂ÷ : 2021-11-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Àü³²´ëÇб³º´¿ø (¿Â¶óÀÎ) °íÀ§Çè »ê¸ð ½Å»ý¾Æ ÅëÇÕÄ¡·á¼¾ÅÍ °³¼Ò 4Áֳ⠱â³ä ¿Â¶óÀÎ ½ÉÆ÷Áö¾ö : 2021-11-12
´ÙÀ½±Û ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ KATRDIC(The Korean Academy of Tuberculosis and Respiratory Diseases) 2021(Á¦132Â÷ Ãß°èÇмú´ëȸ) 2ÀÏÂ÷ : 2021-11-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 48 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 43 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 38 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 51 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 38 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 73 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 28 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 39 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 38 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 45 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 43 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 32 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 36 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 41 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 45 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷